EP1161375B1 - Cumulative packaging provided for the removal of filled pouches in a predetermined order - Google Patents
Cumulative packaging provided for the removal of filled pouches in a predetermined order Download PDFInfo
- Publication number
- EP1161375B1 EP1161375B1 EP00912571A EP00912571A EP1161375B1 EP 1161375 B1 EP1161375 B1 EP 1161375B1 EP 00912571 A EP00912571 A EP 00912571A EP 00912571 A EP00912571 A EP 00912571A EP 1161375 B1 EP1161375 B1 EP 1161375B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- bags
- multipack
- edges
- bag
- superposed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D33/00—Details of, or accessories for, sacks or bags
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D33/00—Details of, or accessories for, sacks or bags
- B65D33/001—Blocks, stacks or like assemblies of bags
Definitions
- the invention relates to a packaging of products which for protection in a bag, the packaging being at least two Bags.
- the contents in these bags can be identical or different. Preferably, these contents are to be taken and used in a given order.
- This type of bags are bags that have an interior and a possess this interior enclosing edge, z. B. to the expert known four-edge seal bag. Of course, these bags can also only be sealed three, two or one edge.
- the products are preferably flat systems, for. B. Stickers, labels, tea towels, floppy disks, CD-ROMs, chip cards, Coins, stamps, flat systems for oral or transdermal Application or patch and the like.
- these patches can z.
- B. under a Hormone replacement therapy can be used in a way that in a first phase (duration about 14 days) on every third day Patch containing an estrogen, and in a second phase (Duration about 14 days) on each third day each containing a patch an estrogen and a gestagen is applied. With such a therapy So first you need about 4 plasters of the first phase and then about 4 Patches of the second phase are used.
- the object of the invention is therefore to simplify the administration this patch in the proposed therapy plan and to avoid Confusions to provide a multipack that has a certain number of area systems, eg. B. a total of 8 plasters in the respective bags in the required order and in a block contains connected to each other.
- a certain number of area systems eg. B. a total of 8 plasters in the respective bags in the required order and in a block contains connected to each other.
- CH 339 119 is an album from a series of flat Bag revealed. These bags are made of transparent material and contain different plant seeds. They also indicate Pictures of the respective plant. It is not in the document described that the bags in a predetermined order too You can see the order of the bags within the album equivalent. Also, no flat systems are disclosed as products. On Fan fanning - as stated in this document Drawing is shown - therefore can not be prevented.
- a packaging for products which individually in Bag or in several cells are packed on a blackboard.
- characteristic for this packaging is a printed outer coat, which takes the form of a inverted U's and in which the individual bags or the panels with arranged thereon, product-filled cells are inserted at the top.
- This Packaging may be equipped with a label closure and have a fastening system for a pin. Even if it is It should be noted that such packaging for bandages and pharmaceutical products are suitable, but the reference to Products, the two-dimensional systems for oral or transdermal application represent. An indication of a specific order in which the bags be placed inside the multipack, is completely missing. Also Here, the problem of fanning the individual bags is not addressed.
- the bags have an interior and have an edge enclosing this interior, at least two bags are grouped into one block, within this one Blocks a section of the edge of a first bag to the section of the Rands of an adjacent second bag essentially nationwide on top of each other, and within this block so the one above the other lying portions of the edges of each adjacent bag firmly connected to each other.
- This block can also be provided with a back.
- the back can be replaced by a re-closable envelope be wrapped around the bags.
- the closure of the envelope can additionally with a closure seal, so that the buyer of the Pack can detect if the packaging is still intact.
- Such Seal is z.
- the materials that make up the back or the envelope may consist of paper, cardboard, cardboard, plastic, metal, elastic plastic film, composite materials such as metal and / or plastic-coated paper, etc.
- the block itself can be provided with a closure seal his.
- a closure seal his there is such a seal (sticker) z.
- This collective pack (so-called calendar pack, that is the block of several firmly connected bags) can subsequently in a conventional carton.
- calendar pack that is the block of several firmly connected bags
- For large packs can several of these collective packs in a carton summarized become.
- the interior of the contents of the bag has a certain thickness owns a fuzz in a block containing multiple bags These bags occur, but by using spacers can be avoided.
- the spacers preferably have a thickness that is the thickness of the contents of a bag equivalent. Adjusting the thickness of the adhesive layer or the adhesive film does not have to be done.
- the user eg patient first removes the multipack of the Folding box. Due to the tamper-evident closure (ie the uninjured Closing seal), he can determine whether the multipack already open has been. After opening the seal, the user first removes the top bag, since this is offered to him and the easiest to remove is. Through the back or the envelope is prevented the user a bag from the back and thus in the wrong, d. H. takes in reverse order. When removing the first bag the composite of the remaining bags is not destroyed and the required Order remains. The remaining bags are then protected by the closure of the envelope.
- the tamper-evident closure ie the uninjured Closing seal
- the portion of the edge of a first bag with the portion of the edge of an adjacent second Bag so superimposed that the respective edges of these edges slightly parallel has the Advantage that when using an adhesive as a connecting device the Contact surface between glue and bag film is enlarged and thus a better hold of the bag is created. Also, this facilitates the use an adhesive tape as a connecting device.
- the extent of Parallel displacement generally depends on the thickness of the bags and in a preferred embodiment is at least 0.3 each mm.
- this manufacturing process will be after stacking the bags to be permanently attached to them shifted slightly parallel (preferably at least about each 0.3 mm), so that on subsequent joining the superimposed lying portions of the edges of the bag by means of z.
- B. adhesives Contact surface between glue and bag is increased.
- the bags of a multipack two different types of content (eg two TTS with different Active ingredients or Wirkstoffkombinatonnen) contained in a given order, the order of the bags within the Multipack (from the top toward the back) corresponds, taken Need to become.
- two different types of content eg two TTS with different Active ingredients or Wirkstoffkombinatonnen
- the multipack in a method for transdermal administration of hormones in which a first Treatment phase at least one transdermal therapeutic system (TTS) containing at least one estrogen and in one second treatment phase at least one transdermal therapeutic System is administered containing at least one estrogen and a progestin contains, used.
- TTS transdermal therapeutic system
- This is from the multipack at the beginning the first treatment phase at least one bag containing a transdermal therapeutic system with at least one estrogen and on the skin of a user applied, and from the said multipack at the beginning of the second Treatment phase at least one bag containing a transdermal therapeutic system with at least one estrogen and one Progestogen taken and applied to the skin of a user or a Applicant applied.
- the concrete number of the bags of the collective pack is in this case according to which administration period the individual transdermal therapeutic systems are designed.
- the transdermal therapeutic systems e.g. B. is plaster, which from the Users are worn three days each should be a total of two times four TTS or twice five TTS, with the number two on the different TTS types (containing estrogen or estrogen and gestagen).
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Packages (AREA)
- Bag Frames (AREA)
- Control And Other Processes For Unpacking Of Materials (AREA)
- Supplying Of Containers To The Packaging Station (AREA)
- Sheets, Magazines, And Separation Thereof (AREA)
- Containers And Plastic Fillers For Packaging (AREA)
- Examining Or Testing Airtightness (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
Abstract
Description
Die Erfindung betrifft eine Verpackung von Produkten, welche zum Schutz in einem Beutel verpackt sind, wobei die Verpackung aus mindestens zwei Beuteln besteht. Die in diesen Beuteln befindlichen Inhalte (Produkte) können identisch oder verschiedenen sein. Vorzugsweise sind diese Inhalte in einer vorgegebenen Reihenfolge zu entnehmen und zu verwenden. Bei dieser Art von Beuteln handelt es sich Beutel, die einen Innenraum und einen diesen Innenraum umschliessenden Rand besitzen, z. B. um dem Fachmann bekannte Vierrandsiegelbeutel. Natürlich können diese Beutel auch nur an drei, zwei oder einem Rand versiegelt sein.The invention relates to a packaging of products which for protection in a bag, the packaging being at least two Bags. The contents in these bags (products) can be identical or different. Preferably, these contents are to be taken and used in a given order. at This type of bags are bags that have an interior and a possess this interior enclosing edge, z. B. to the expert known four-edge seal bag. Of course, these bags can also only be sealed three, two or one edge.
Bei den Produkten handelt es sich bevorzugt um flächige Systeme, z. B. Aufkleber, Etiketten, Erfrischungstüchern, Disketten, CD-ROMs, Chipkarten, Münzen, Briefmarken, flächige Systeme für die orale oder transdermale Applikation oder Pflaster und ähnliches. In einer besonderen Ausführungsform handelt es sich dabei um gleiche und / oder verschiedene Hormonpflaster (Transdermale Therapeutische Systeme mit Sexualhormonen). Diese Pflaster können z. B. im Rahmen einer Hormonsubstitutionstherapie in einer Weise verwendet werden, bei der in einer ersten Phase (Dauer etwa 14 Tage) an jedem dritten Tag jeweils ein Pflaster enthaltend ein Oestrogen appliziert wird, und in einer zweiten Phase (Dauer etwa 14 Tage) an jedem dritten Tag jeweils ein Pflaster enthaltend ein Oestrogen und ein Gestagen appliziert wird. Bei einer solchen Therapie müssen also zuerst etwa 4 Pflaster der ersten Phase und danach etwa 4 Pflaster der zweiten Phase verwendet werden.The products are preferably flat systems, for. B. Stickers, labels, tea towels, floppy disks, CD-ROMs, chip cards, Coins, stamps, flat systems for oral or transdermal Application or patch and the like. In a special Embodiment, these are the same and / or different Hormone patches (Transdermal Therapeutic Systems with Sex hormones). These patches can z. B. under a Hormone replacement therapy can be used in a way that in a first phase (duration about 14 days) on every third day Patch containing an estrogen, and in a second phase (Duration about 14 days) on each third day each containing a patch an estrogen and a gestagen is applied. With such a therapy So first you need about 4 plasters of the first phase and then about 4 Patches of the second phase are used.
Aufgabe der Erfindung ist es daher, zur Vereinfachung der Verabreichung dieser Pflaster in dem vorgesehenen Therapieplan und zur Vermeidung von Verwechslungen eine Sammelpackung zur Verfügung zu stellen, die eine bestimmte Anzahl von flächigen Systemen, z. B. insgesamt 8 Pflaster in den jeweiligen Beuteln in der geforderten Reihenfolge und in einem Block miteinander verbunden enthält.The object of the invention is therefore to simplify the administration this patch in the proposed therapy plan and to avoid Confusions to provide a multipack that has a certain number of area systems, eg. B. a total of 8 plasters in the respective bags in the required order and in a block contains connected to each other.
In der Patentschrift CH 339 119 wird ein Album aus einer Serie von flachen Säckchen offenbart. Diese Säckchen bestehen aus transparentem Material und enthalten verschiedene Pflanzensamen. Sie weisen zusätzlich Abbildungen der jeweiligen Pflanze auf. Es ist in dem Dokument nicht beschrieben, daß die Säckchen in einer vorgegebenen Reihenfolge zu entnehmen sind, die der Reihenfolge der Säckchen innerhalb des Albums entspricht. Auch sind als Produkte keine flächigen Systeme offenbart. Ein Auffächern der Beutel - wie dies in der diesem Dokument beigefügten Zeichnung dargestellt ist - kann deshalb nicht verhindert werden.In the patent CH 339 119 is an album from a series of flat Bag revealed. These bags are made of transparent material and contain different plant seeds. They also indicate Pictures of the respective plant. It is not in the document described that the bags in a predetermined order too You can see the order of the bags within the album equivalent. Also, no flat systems are disclosed as products. On Fan fanning - as stated in this document Drawing is shown - therefore can not be prevented.
Aus FR 2,629,797 ist eine Verpackung für Produkte bekannt, die einzeln in Beutel oder in mehreren Zellen auf einer Tafel verpackt sind. Kennzeichnend für diese Verpackung ist ein bedruckter äußerer Mantel, der die Form eines umgekehrten U's besitzt und in den die einzelnen Beutel bzw. die Tafeln mit den darauf angeordneten, produktbefüllten Zellen oben eingelegt sind. Dies Verpackungen können mit einem Etikettenverschluss ausgerüstet sein und ein Befestigungssystem für einen Zapfen besitzen. Auch wenn darauf hingewiesen wird, daß solche Verpackungen für Verbandmaterial und pharmazeutische Produkte geeignet sind, fehlt doch der Hinweis auf Produkte, die flächige Systeme für die orale oder transdermale Applikation darstellen. Ein Hinweis auf eine bestimmte Reihenfolge, in der die Beutel innerhalb der Sammelpackung angeordnet werden müssen, fehlt völlig. Auch hier wird das Problem des Auffächerns der einzelnen Beutel nicht angesprochen.From FR 2,629,797 a packaging for products is known which individually in Bag or in several cells are packed on a blackboard. characteristic for this packaging is a printed outer coat, which takes the form of a inverted U's and in which the individual bags or the panels with arranged thereon, product-filled cells are inserted at the top. This Packaging may be equipped with a label closure and have a fastening system for a pin. Even if it is It should be noted that such packaging for bandages and pharmaceutical products are suitable, but the reference to Products, the two-dimensional systems for oral or transdermal application represent. An indication of a specific order in which the bags be placed inside the multipack, is completely missing. Also Here, the problem of fanning the individual bags is not addressed.
Gelöst wird die Aufgabe durch eine Sammelpackung nach Anspruch 1 und ein Verfahren nach Anspruch 8,
wobei die Beutel einen Innenraum und
einen diesen Innenraum umschliessenden Rand besitzen, mindestens
zwei Beutel zu einem Block zusammengefasst sind, innerhalb dieses
Blocks ein Abschnitt des Rands eines ersten Beutels mit dem Abschnitt des
Rands eines benachbarten zweiten Beutels im wesentlichen flächendeckend
übereinander liegt, und wobei innerhalb dieses Blocks die so übereinander
liegenden Abschnitte der Ränder der jeweils benachbarten Beutel fest
miteinander verbunden sind.The object is achieved by a multipack according to
Dieser Block kann zusätzlich mit einem Rücken versehen werden. Zum Schutz der Beutel gegen Verschmutzung und mechanische Beschädigung kann der Rücken durch einen wieder verschliessbaren Umschlag ersetzt werden, der die Beutel umhüllt. Der Verschluss des Umschlags kann zusätzlich mit einem Verschlusssiegel erfolgen, so dass der Käufer der Packung erkennen kann, ob die Verpackung noch unversehrt ist. Ein solches Siegel ist z. B. ein Aufkleber, der auf zwei aufeinander geklappten Umschlagdeckel geklebt wird. Die Materialien, aus denen der Rücken oder der Umschlag bestehen, können Papier, Pappe, Karton, Kunststoff, Metall, elastische Kunststofffolie, Verbundmaterialien wie metall- und / oder kunststoffbeschichtetes Papier etc. sein.This block can also be provided with a back. To the Protection of bags against contamination and mechanical damage The back can be replaced by a re-closable envelope be wrapped around the bags. The closure of the envelope can additionally with a closure seal, so that the buyer of the Pack can detect if the packaging is still intact. Such Seal is z. B. a sticker that folded on two Cover is glued. The materials that make up the back or the envelope may consist of paper, cardboard, cardboard, plastic, metal, elastic plastic film, composite materials such as metal and / or plastic-coated paper, etc.
Allerdings kann auch der Block selbst mit einem Verschlusssiegel versehen sein. In diesem Fall befindet sich ein solches Siegel (Aufkleber) z. B. seitlich oder gegenüber liegend der Verbindungsvorrichtung, die die übereinander liegenden Abschnitte der Ränder der jeweils benachbarten Beutel fest miteinander verbindet.However, the block itself can be provided with a closure seal his. In this case, there is such a seal (sticker) z. B. laterally or opposite the connecting device, which are the one above the other lying portions of the edges of each adjacent bag firmly connects with each other.
Diese Sammelpackung (sog. Kalenderpackung, d. h. der Block von mehreren fest miteinander verbundenen Beuteln) kann anschliessend in einer herkömmlichen Faltschachtel verpackt werden. Bei Grosspackungen können mehrere dieser Sammelpackungen in einer Faltschachtel zusammengefasst werden.This collective pack (so-called calendar pack, that is the block of several firmly connected bags) can subsequently in a conventional carton. For large packs can several of these collective packs in a carton summarized become.
Sofern der im Innenraum befindliche Inhalt der Beutel eine gewisse Dicke besitzt kann bei einem Block, der mehrere Beutel enthält, ein Auffächern dieser Beutel auftreten, was aber durch Verwendung von Abstandhaltern vermieden werden kann.Provided that the interior of the contents of the bag has a certain thickness owns a fuzz in a block containing multiple bags These bags occur, but by using spacers can be avoided.
Dazu wird innerhalb dieses Blocks zwischen dem Abschnitt des Rands eines ersten Beutels und dem im wesentlichen flächendeckend darüber liegenden Abschnitt des Rands eines benachbarten zweiten Beutels ein Abstandhalter eingelegt (siehe Abbildung 6) und dann innerhalb dieses Blocks die so übereinander liegenden Abschnitte der Ränder der jeweils benachbarten Beutel und die dazwischen liegenden Abstandhalter (z. B.: Folie aus Kunststoff, Papierstreifen) fest miteinander verbunden. Die Abstandhalter besitzen vorzugsweise eine Dicke, die der Dicke des Inhalts eines Beutels entspricht. Ein Anpassen der Dicke der Klebeschicht bzw. der Klebefolie muss nicht erfolgen.This is done within this block between the section of the edge of a first bag and the substantially nationwide overlying Section of the edge of an adjacent second bag a spacer inserted (see Figure 6) and then within this block the so superimposed portions of the edges of each adjacent Pouch and the intermediate spacers (eg: foil out Plastic, paper strip) firmly connected. The spacers preferably have a thickness that is the thickness of the contents of a bag equivalent. Adjusting the thickness of the adhesive layer or the adhesive film does not have to be done.
Der Anwender (z. B. Patient) entnimmt zuerst die Sammelpackung der Faltschachtel. Durch den Originalitätsverschluss (d. h. das unverletzte Verschlusssiegel) kann er feststellen, ob die Sammelpackung schon geöffnet wurde. Nach dem Öffnen des Siegels entnimmt der Anwender zuerst den obersten Beutel, da ihm dieser angeboten wird und am einfachsten zu entfernen ist. Durch den Rücken bzw. den Umschlag wird verhindert, dass der Anwender einen Beutel von hinten und somit in der falschen, d. h. umgekehrten Reihenfolge entnimmt. Beim Entnehmen des ersten Beutels wird der Verbund der verbleibenden Beutel nicht zerstört und die geforderte Reihenfolge bleibt erhalten. Die verbleibenden Beutel werden anschliessend durch das Verschliessen des Umschlags geschützt. The user (eg patient) first removes the multipack of the Folding box. Due to the tamper-evident closure (ie the uninjured Closing seal), he can determine whether the multipack already open has been. After opening the seal, the user first removes the top bag, since this is offered to him and the easiest to remove is. Through the back or the envelope is prevented the user a bag from the back and thus in the wrong, d. H. takes in reverse order. When removing the first bag the composite of the remaining bags is not destroyed and the required Order remains. The remaining bags are then protected by the closure of the envelope.
Durch Aufdrucke (z. B. Nummern, Datum) auf den einzelnen Beuteln kann die vorgesehene Entnehmreihenfolge der Beutel bzw. Applikationsreihenfolge der Inhalte (Pflaster, TTS) zusätzlich angegeben werden.By imprints (eg, numbers, date) on the individual bags can the intended removal order of the bag or Order of application of the contents (patch, TTS) additionally indicated become.
In einer besonderen Ausführungsform wird der Abschnitt des Rands eines ersten Beutels mit dem Abschnitt des Rands eines benachbarten zweiten Beutels so übereinander gelegt, dass die jeweiligen Kanten dieser Ränder geringfügig parallel verschoben sind (siehe Abbildung 7). Dies hat den Vorteil, dass bei Verwendung eines Klebers als Verbindungsvorrichtung die Kontaktfläche zwischen Kleber und Beutelfolie vergrössert wird und somit ein besserer Halt der Beutel entsteht. Auch erleichtert dies die Verwendung eines Klebebands als Verbindungsvorrichtung. Das Ausmass der Parallelverschiebung richtet sich im allgemeinen nach der Dicke der Beutel und beträgt in einer bevorzugten Ausführungsform mindestens jeweils 0,3 mm.In a particular embodiment, the portion of the edge of a first bag with the portion of the edge of an adjacent second Bag so superimposed that the respective edges of these edges slightly parallel (see Figure 7). This has the Advantage that when using an adhesive as a connecting device the Contact surface between glue and bag film is enlarged and thus a better hold of the bag is created. Also, this facilitates the use an adhesive tape as a connecting device. The extent of Parallel displacement generally depends on the thickness of the bags and in a preferred embodiment is at least 0.3 each mm.
Die Herstellung solcher Sammelpackungen erfolgt in den Schritten:
Gegebenenfalls werden bereits im Rahmen der Herstellung der produktgefüllten Beutel Perforationslinien oder andere Sollbruchlinien in den Rand der Beutel eingestanzt. If necessary, already in the context of the production of Product filled bag Perforation lines or other break lines in the Punched edge of the bag.
Gegebenenfalls wird vor oder nach dem dauerhaften Verbinden der übereinanderliegenden Abschnitte der Ränder noch ein Rücken oder Umschlag unter die übereinandergelegten Beutel gelegt.Optionally, before or after permanently connecting the superimposed sections of the edges still have a back or Envelope placed under the superimposed bag.
In einer besonderen Ausführungsform dieses Herstellungsverfahrens werden nach dem Übereinanderiegen der dauerhaft zu verbindenden Beutel diese geringfügig parallel verschoben (vorzugsweise jeweils um mindestens etwa 0,3 mm), so dass beim nachfolgenden Verbinden der übereinander liegenden Abschnitte der Ränder der Beutel mit Hilfe von z. B. Klebern die Kontaktfläche zwischen Kleber und Beutel vergrössert wird.In a particular embodiment of this manufacturing process will be after stacking the bags to be permanently attached to them shifted slightly parallel (preferably at least about each 0.3 mm), so that on subsequent joining the superimposed lying portions of the edges of the bag by means of z. B. adhesives Contact surface between glue and bag is increased.
In einer weiteren Ausführungsform können die Beutel einer Sammelpackung zwei verschiedene Arten von Inhalten (z. B. zwei TTS mit verschiedenen Wirkstoffen bzw. Wirkstoffkombinaticnen) enthalten, die in einer vorgegebenen Reihenfolge, die der Reihenfolge der Beutel innerhalb der Sammelpackung (von oben in Richtung Rücken) entspricht, entnommen werden müssen.In a further embodiment, the bags of a multipack two different types of content (eg two TTS with different Active ingredients or Wirkstoffkombinatonnen) contained in a given order, the order of the bags within the Multipack (from the top toward the back) corresponds, taken Need to become.
Erfindungsgemäss kann die Sammelpackung bei einem Verfahren zur transdermalen Verabreichung von Hormonen, bei dem in einer ersten Behandlungsphase mindestens ein transdermales therapeutisches System (TTS) verabreicht wird, das mindestens ein Oestrogen enthält, und in einer zweiten Behandlungsphase mindestens ein transdermales therapeutisches System verabreicht wird, das mindestens ein Oestrogen und ein Gestagen enthält, verwendet werden. Dazu wird aus der Sammelpackung zu Beginn der ersten Behandlungsphase mindestens ein Beutel, enthaltend ein transdermales therapeutisches System mit mindestens einem Oestrogen entnommen und auf die Haut eines Anwenders oder einer Anwenderin appliziert, und aus der besagten Sammelpackung zu Beginn der zweiten Behandlungsphase mindestens ein Beutel, enthaltend ein transdermales therapeutisches System mit mindestens einem Oestrogen und einem Gestagen entnommen und auf die Haut eines Anwenders oder einer Anwenderin appliziert.According to the invention, the multipack in a method for transdermal administration of hormones, in which a first Treatment phase at least one transdermal therapeutic system (TTS) containing at least one estrogen and in one second treatment phase at least one transdermal therapeutic System is administered containing at least one estrogen and a progestin contains, used. This is from the multipack at the beginning the first treatment phase at least one bag containing a transdermal therapeutic system with at least one estrogen and on the skin of a user applied, and from the said multipack at the beginning of the second Treatment phase at least one bag containing a transdermal therapeutic system with at least one estrogen and one Progestogen taken and applied to the skin of a user or a Applicant applied.
Die konkrete Zahl der Beutel der Sammelpackung richtet sich in diesem Fall danach, für welchen Verabreichungszeitraum die einzelnen transdermalen therapeutischen Systeme konzipiert sind. Wenn es sich bei den transdermalen therapeutischen Systemen z. B. um Pflaster handelt, die vom Anwender bzw. der Anwenderin jeweils drei über Tage getragen werden sollen, empfiehlt sich eine Gesamtzahl von zwei mal vier TTS oder zwei mal fünf TTS, wobei sich die Zahl zwei auf die unterschiedlichen TTS-Typen (oestrogenhaltig bzw. oestrogen- und gestagenhaltig) bezieht.The concrete number of the bags of the collective pack is in this case according to which administration period the individual transdermal therapeutic systems are designed. When it comes to the transdermal therapeutic systems e.g. B. is plaster, which from the Users are worn three days each should be a total of two times four TTS or twice five TTS, with the number two on the different TTS types (containing estrogen or estrogen and gestagen).
Anhand der Abbildungen 1 bis 7 werden Ausführungsformen der
erfindungsgemässen Sammelpackung erläutert:
Claims (12)
- Multipack with at least two bags (2, 5, 7, 11, 12) which are to be removed in a predetermined sequence which corresponds to the sequence of the bags within the multipack, where the bags (2, 5, 7, 11, 12) have an inner area and an edge enclosing this inner area, and at least two of them are joined together to form a block, and where, within this block, a section of the edge (9) of a first bag lies almost over the whole surface of the section of the edge (9) of an adjacent second bag, and the thereby superposed sections of the edges of the respectively adjacent bags are firmly connected to one another, the bags having different contents characterized in that the contents are planar systems for oral or transdermal application.
- Multipack according to Claim 1, characterized in that the planar systems for transdermal application are transdermal therapy systems (TTS) with sex hormones.
- Multipack according to Claim 1 or 2, characterized in that the block comprising at least two bags additionally includes a backing (1, 8) or a resealable cover (4).
- Multipack according to one of Claims 1 through 3, characterized in that the block comprising at least two bags additionally includes a closure seal.
- Multipack according to one of Claims 1 through 4, characterized in that the superposed sections of the edges (9) of respectively adjacent bags are connected with the aid of a hot-melt adhesive, an adhesive tape, glue, staples, a sealing medium or a double-sided adhesive tape.
- Multipack according to one of Claims 1 through 5, characterized in that the bags have a perforation line (10) on an edge enclosing the inner area, and the superposed sections of the edges of respectively adjacent bags are limited by this perforation line.
- Multipack according to one of Claims 1 through 6, charaterized in that the respective margins of the superposed sections of the edges (9) of adjacent bags are offset in parallel and/or the superposed sections of the edges have spacers (13) lying between them.
- Method for producing a multipack with at least two bags (2, 5, 7, 11, 12), the bags having an inner area and an edge enclosing the inner area and the bags being filled with products, these products being planar systems for oral or transdermal application in whicha) the section of the edge (9) of a first product-filled bag is superposed on substantially the whole surface of the section of the edge (9) of an adjacent second product-filled bag,b) the margins of those sections of the edges of the product-filled bags which are to be superposed are offset in parallel in the direction of the opposite edges, andc) the superposed sections of the edges of the product-filled bags are permanently connected.
- Method for producing a multipack according to Claim 8, characterized in that a perforation line (10) is additionally incorporated in those sections of the edges (9) of the product-filled bags which are to be superposed.
- Method for producing a multipack according to either of Claims 8 or 9, characterized in that spacers (13) are additionally inserted between those sections of the edges (9) of the product-filled bags which are to be superposed.
- Use of a multipack according to one of Claims 1 to 7 for removing individual bags in a predetermined sequence which corresponds to the sequence of the bags within the multipack.
- Use of a multipack according to Claim 11 in a method for trandermal administration of hormones, in whicha) at the start of a first treatment phase, at least one bag containing a transdermal therapy system with at least one oestrogen is removed, andb) at the start of a second treatment phase, at least one bag containing a transdermal therapy system with at least one oestrogen and one gestagen is removed.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19911799A DE19911799A1 (en) | 1999-03-17 | 1999-03-17 | Multipack for the removal of filled bags in the specified order |
DE19911799 | 1999-03-17 | ||
PCT/EP2000/002043 WO2000055061A1 (en) | 1999-03-17 | 2000-03-09 | Cumulative packaging provided for the removal of filled pouches in a predetermined order |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1161375A1 EP1161375A1 (en) | 2001-12-12 |
EP1161375B1 true EP1161375B1 (en) | 2003-09-17 |
Family
ID=7901234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00912571A Expired - Lifetime EP1161375B1 (en) | 1999-03-17 | 2000-03-09 | Cumulative packaging provided for the removal of filled pouches in a predetermined order |
Country Status (10)
Country | Link |
---|---|
US (2) | US7004321B1 (en) |
EP (1) | EP1161375B1 (en) |
JP (1) | JP4494646B2 (en) |
KR (1) | KR100665434B1 (en) |
AT (1) | ATE249976T1 (en) |
AU (1) | AU3428300A (en) |
DE (2) | DE19911799A1 (en) |
DK (1) | DK1161375T3 (en) |
ES (1) | ES2207491T3 (en) |
WO (1) | WO2000055061A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007131615A1 (en) | 2006-05-12 | 2007-11-22 | Lts Lohmann Therapie-Systeme Ag | Pouch-based cumulative packaging |
DE102007037374A1 (en) * | 2007-08-06 | 2009-02-12 | Bayer Schering Pharma Aktiengesellschaft | Apparatus and use for storing and providing drug wafers |
DE102009008027A1 (en) * | 2009-02-06 | 2010-08-12 | Bayer Schering Pharma Aktiengesellschaft | Device and use for storage and provision of drug wafers |
DE102009008026A1 (en) * | 2009-02-06 | 2010-08-12 | Bayer Schering Pharma Aktiengesellschaft | Method for producing stack of medicament pockets that is utilized for storing and providing medicament wafers for e.g. contraception, involves stacking pockets so that markings are arranged in marking sections of pockets within each stack |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008116177A1 (en) * | 2007-03-21 | 2008-09-25 | Wm. Wrigley Jr. Company | Confectionery product package |
AU2010202571B2 (en) | 2009-07-29 | 2015-10-01 | Mcneil-Ppc, Inc. | Packaging |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (en) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | pharmaceutical composition of steroid hormone |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US447712A (en) * | 1891-03-03 | Oie coupling | ||
GB447712A (en) * | 1935-06-20 | 1936-05-25 | William Warren Triggs | Improvements relating to the packaging of articles |
US2715493A (en) * | 1948-12-23 | 1955-08-16 | Clarence W Vogt | Chained enwrapments |
US2653751A (en) * | 1949-01-14 | 1953-09-29 | Clarence W Vogt | Chain of bags |
DE1027844B (en) * | 1954-05-12 | 1958-04-10 | Hans Neschen | Storage pack for several wound plasters on top of each other |
DE1683678U (en) * | 1954-06-28 | 1954-09-23 | Willi Maurer K G | SMALL LETTER PACKAGE, IN PARTICULAR FOR POWDER-FORMED SUBSTANCES. |
CH339119A (en) * | 1957-08-13 | 1959-06-15 | Vatter Richard | Notebook for the presentation and sale of vegetable seeds |
DE1823247U (en) * | 1960-06-01 | 1960-12-08 | Global Synthetic G M B H | POCKET OR BAG-SHAPED SERIES PACKAGING FOR COMMERCIAL GOODS. |
JPS4928905Y1 (en) * | 1969-06-23 | 1974-08-06 | ||
AT330646B (en) * | 1972-04-08 | 1976-07-12 | Windmoeller & Hoelscher | TEAR BLOCK FOR BAGS, IN PARTICULAR MADE OF PLASTIC FILM |
US3915302A (en) * | 1974-10-07 | 1975-10-28 | Vac Pac Mfg Co | Imbricated package of closed-end bags |
ZA763874B (en) | 1975-07-03 | 1977-05-25 | American Minechem Corp | Method for transporting coal |
JPS5280587U (en) * | 1975-12-12 | 1977-06-16 | ||
GB1574347A (en) * | 1977-10-06 | 1980-09-03 | Salve Sa | Package |
US4502599A (en) | 1984-04-02 | 1985-03-05 | Minnesota Mining And Manufacturing Company | Package and method of packaging resealable plastic bags |
JPS62128544U (en) * | 1986-02-07 | 1987-08-14 | ||
US5422119A (en) * | 1987-09-24 | 1995-06-06 | Jencap Research Ltd. | Transdermal hormone replacement therapy |
EP0309263B1 (en) * | 1987-09-24 | 1994-03-09 | Jencap Research Limited | Hormone composition and use |
FR2629797A1 (en) * | 1988-04-07 | 1989-10-13 | Raffegeau Didier | Outer packaging for products packed individually in sachets or in cellular panels |
DE8811648U1 (en) * | 1988-09-14 | 1988-11-10 | Franz, Lotte, 6082 Walldorf | Packaging unit for paper tissues |
JPH0285157A (en) * | 1988-09-20 | 1990-03-26 | Asahi Chem Ind Co Ltd | Piled-up housing bag |
DE69007886T2 (en) * | 1989-07-21 | 1994-11-17 | Izhak Blank | Oestradiol containing agents and methods for topical use. |
EP0447712A3 (en) | 1990-03-22 | 1991-11-06 | Kabushiki Kaisha Oh-Yoh Keisoku Kenkyusho | Motion analysing/advising system |
DE4223004A1 (en) | 1992-07-13 | 1994-01-20 | Liedtke Pharmed Gmbh | Single-dose semi-solid topical dosage form for transdermal therapy |
JPH085453B2 (en) * | 1993-03-30 | 1996-01-24 | 株式会社三橋製作所 | Pouch set and its supply device |
JPH08187269A (en) * | 1994-11-10 | 1996-07-23 | Aanesu:Kk | File for housing medicine |
DE4440727A1 (en) * | 1994-11-15 | 1996-05-23 | Beiersdorf Ag | Multi-pack for sterile plasters, saving packaging material |
JP3763726B2 (en) | 1999-07-14 | 2006-04-05 | キヤノンファインテック株式会社 | Inkjet recording device |
-
1999
- 1999-03-17 DE DE19911799A patent/DE19911799A1/en not_active Ceased
-
2000
- 2000-03-09 WO PCT/EP2000/002043 patent/WO2000055061A1/en active IP Right Grant
- 2000-03-09 EP EP00912571A patent/EP1161375B1/en not_active Expired - Lifetime
- 2000-03-09 JP JP2000605499A patent/JP4494646B2/en not_active Expired - Lifetime
- 2000-03-09 US US09/936,545 patent/US7004321B1/en not_active Expired - Lifetime
- 2000-03-09 DK DK00912571T patent/DK1161375T3/en active
- 2000-03-09 AT AT00912571T patent/ATE249976T1/en active
- 2000-03-09 AU AU34283/00A patent/AU3428300A/en not_active Abandoned
- 2000-03-09 KR KR1020017011722A patent/KR100665434B1/en active IP Right Grant
- 2000-03-09 DE DE50003727T patent/DE50003727D1/en not_active Expired - Lifetime
- 2000-03-09 ES ES00912571T patent/ES2207491T3/en not_active Expired - Lifetime
-
2004
- 2004-04-15 US US10/824,988 patent/US6905705B2/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007131615A1 (en) | 2006-05-12 | 2007-11-22 | Lts Lohmann Therapie-Systeme Ag | Pouch-based cumulative packaging |
DE102006022198B4 (en) * | 2006-05-12 | 2008-08-21 | Lts Lohmann Therapie-Systeme Ag | Bag multipack |
US8944247B2 (en) | 2006-05-12 | 2015-02-03 | Lts Lohmann Therapie Systeme Ag | Pouch-based cumulative packaging |
DE102007037374A1 (en) * | 2007-08-06 | 2009-02-12 | Bayer Schering Pharma Aktiengesellschaft | Apparatus and use for storing and providing drug wafers |
DE102007037374B4 (en) * | 2007-08-06 | 2009-04-23 | Bayer Schering Pharma Aktiengesellschaft | Apparatus and use for storing and providing drug wafers |
DE102009008027A1 (en) * | 2009-02-06 | 2010-08-12 | Bayer Schering Pharma Aktiengesellschaft | Device and use for storage and provision of drug wafers |
DE102009008026A1 (en) * | 2009-02-06 | 2010-08-12 | Bayer Schering Pharma Aktiengesellschaft | Method for producing stack of medicament pockets that is utilized for storing and providing medicament wafers for e.g. contraception, involves stacking pockets so that markings are arranged in marking sections of pockets within each stack |
Also Published As
Publication number | Publication date |
---|---|
US6905705B2 (en) | 2005-06-14 |
ATE249976T1 (en) | 2003-10-15 |
EP1161375A1 (en) | 2001-12-12 |
AU3428300A (en) | 2000-10-04 |
WO2000055061A1 (en) | 2000-09-21 |
ES2207491T3 (en) | 2004-06-01 |
DE19911799A1 (en) | 2000-09-28 |
DK1161375T3 (en) | 2003-12-15 |
US20040232028A1 (en) | 2004-11-25 |
KR20020007328A (en) | 2002-01-26 |
KR100665434B1 (en) | 2007-01-04 |
JP2002539050A (en) | 2002-11-19 |
US7004321B1 (en) | 2006-02-28 |
DE50003727D1 (en) | 2003-10-23 |
JP4494646B2 (en) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1161375B1 (en) | Cumulative packaging provided for the removal of filled pouches in a predetermined order | |
EP1140650B1 (en) | Packaging for planiform objects/products | |
DE69309640T2 (en) | Closure label | |
EP1094430B1 (en) | Multipart label for blister packs, method of fabrication and use | |
DE60310144T2 (en) | SUPPLY VESSEL | |
DE4429503C2 (en) | Package, especially pharmaceutical package | |
DE2622109A1 (en) | LADIES BINDINGS | |
CH642026A5 (en) | EMPTY PACKING FOR INSERTING BLISTER STRIPES AND BLISTER PACK. | |
DE202004021140U1 (en) | Medicine pack has blister units with blister strip connected to protective case capable to be unfolded or opened out, and outer package for receiving the blister units and configured so that pack content is fixed in outer package inside | |
DE69506267T2 (en) | BLISTER PACK WITH DRYING AGENT | |
EP2175827B1 (en) | Device and use for storing and providing pharmaceutical wafers | |
DE69201753T2 (en) | Device for closing and opening a plastic film bag. | |
WO2001040073A1 (en) | Packaging for moist tissues or similar consumable articles | |
DE60011888T2 (en) | LABELS AND LABELED PACKAGING | |
DE2418999A1 (en) | X-RAY FILM PACKAGING | |
DD283562A5 (en) | PRIMARY PACKAGING FOR FLAEZE-STABILIZED FASCINATES | |
EP1107213A2 (en) | Label composed of different parts ,its manufacture and use | |
EP0520330B1 (en) | Packaged dressings and medical adhesive materials, and their production | |
DE102010028351A1 (en) | wafer pocket | |
EP1227991A1 (en) | Method for packaging objects and a packaging material in the form of a strip | |
DE10056234A1 (en) | Primary packaging for transdermal therapeutic systems or medical plasters | |
EP1019300A1 (en) | Child-proof pack for pressure-sensitive products which also have a comparatively large surface, such as transdermal therapy systems (tts) | |
DE2849960A1 (en) | Printed label for pharmaceutical products - has first section permanently secured to product and second section releasably attached | |
EP2393467A1 (en) | Method for the production of a stack of medicament pouches used for storing and supplying medicament wafers, medicament pouch template for producing said stack, and use of the medicament pouch template | |
DE19909225A1 (en) | Packaging for thin flat objects comprises a carrier card with depressions for the objects to be packaged, and a cover foil which at along the depression boundaries is sealed to the carrier card |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010911 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20020410 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030917 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030917 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 50003727 Country of ref document: DE Date of ref document: 20031023 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031217 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031226 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20031215 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20030917 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040309 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040331 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2207491 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20040618 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20120322 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20120322 Year of fee payment: 13 |
|
REG | Reference to a national code |
Effective date: 20130331 Ref country code: DK Ref legal event code: EBP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130309 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130331 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20190321 Year of fee payment: 20 Ref country code: IT Payment date: 20190325 Year of fee payment: 20 Ref country code: FR Payment date: 20190322 Year of fee payment: 20 Ref country code: GB Payment date: 20190320 Year of fee payment: 20 Ref country code: CH Payment date: 20190320 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20190321 Year of fee payment: 20 Ref country code: NL Payment date: 20190320 Year of fee payment: 20 Ref country code: SE Payment date: 20190320 Year of fee payment: 20 Ref country code: BE Payment date: 20190320 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20190418 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 50003727 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MK Effective date: 20200308 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20200308 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK07 Ref document number: 249976 Country of ref document: AT Kind code of ref document: T Effective date: 20200309 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MK Effective date: 20200309 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20200308 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20200721 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20200310 |